- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00005890
Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
OBJECTIVES:
I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children with septic shock.
II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in children with adrenal dysfunction and septic shock.
Study Overview
Detailed Description
PROTOCOL OUTLINE:
Patients undergo a corticotropin stimulation test within 8 hours of admission to the PICU. Blood samples for plasma cortisol and corticotropin levels are drawn at time 0 followed by corticotropin 1-24 IV. Additional cortisol levels are drawn at 30 and 60 minutes. Corticotropin is measured by immunoradiometric assay and cortisol is measured by radioimmunoassay. Mean arterial blood pressure, heart rate, and respiratory rate are recorded at baseline and at 60 minutes.
Patients receive routine management for septic shock and multiple organ system failure.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229-3039
- Children's Hospital Medical Center - Cincinnati
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Patients admitted to the PICU with septic shock; Hypotension (systolic blood pressure less than 2 standard deviations below age normal) plus 3 or more of the following: temperature greater than 38 or less than 36 degrees Celsius; heart rate greater than 90th percentile for age; respiratory rate greater than 90th percentile for age; WBC greater than 12,000/mm3 or less than 4,000/mm3 or greater than 10% band forms; perfusion abnormalities including lactic acidosis, oliguria, or an acute alteration in mental status
Arterial or central venous catheter in place
--Prior/Concurrent Therapy--
At least one month since prior corticosteroids
--Patient Characteristics--
Renal: No nephrotic syndrome requiring glucocorticoids
Pulmonary: No asthma requiring glucocorticoids
Other: No condition requiring glucocorticoids (e.g., adrenal insufficiency); No uncontrolled diabetes mellitus; No prior adrenal dysfunction (plasma cortisol concentration less than 19 mcg/dL 30 and 60 minutes post corticotropin stimulation); No hypersensitivity to corticotropin
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Richard J. Brilli, Children's Hospital Medical Center, Cincinnati
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCRR-M01RR08084-0043
- CHMC-C-96-3-5
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated...Recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
National Taiwan University HospitalBaxter Healthcare CorporationRecruiting
-
Charite University, Berlin, GermanyCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityUnknown
Clinical Trials on corticotropin
-
Max-Planck-Institute of PsychiatryCompletedHypopituitarismGermany
-
The University of Texas Health Science Center,...CompletedMultiple Sclerosis (MS)United States
-
MallinckrodtCompletedDiabetic NephropathyUnited States
-
The Cleveland ClinicMallinckrodtCompletedPanuveitis | Anterior Uveitis | Ocular SarcoidosisUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedHealthy | Cushing's Syndrome | Adrenal Gland Hyperfunction | Adrenal Gland HypofunctionUnited States
-
Quan Dong NguyenMallinckrodtUnknown
-
Wake Forest University Health SciencesWithdrawn
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
MallinckrodtTerminatedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Neuro-Ophthalmologic Associates, PCMallinckrodtCompletedOptic NeuritisUnited States